Table 2.
Patient’s Characteristics according to pathological Stage and Gleason score
| < pT3a | ≥ pT3a | p | GS < 4 + 3 | GS ≥ 4 + 3 | p | |
|---|---|---|---|---|---|---|
| Patients (%) | 223 (64 %) | 126 (36 %) | 204 (58.5 %) | 145 (41.5 %) | ||
| Age, years | 63.44 ± 6.28 (65;59/68) | 65.97 ± 5.97 (66;62/70) | <0.001 | 63.43 ± 6.16 (64;59/68) | 64.69 ± 6.28 (66;61/69) | 0.158 |
| TRUS Volume, ml | 76 ± 44.05 (60;44/96) | 51.53 ± 29.86 (47;33.6/60) | <0.001 | 56.31 ± 31.57 (50;38/62.5) | 53.23 ± 29.54 (49.5;35.5/57.9) | 0.018 |
| Waist, cm | 99.30 ± 8.13 (98.87;96/102.77) | 100.34 ± 9.22 (98.87;96/102.77) | 0.503 | 99.21 ± 8.88 (99;94/105) | 98.63 ± 10.89 (97;92/103) | 0.549 |
| BMI, kg/m2 | 26.64 ± 3.59 (26.98;24/28.65) | 27.07 ± 3.79 (26.4;24/30) | 0.149 | 26.51 ± 3.54 (26.98;24/28.4) | 27.10 ± 3.8 (26.52;24/29.2) | 0.131 |
| PSA, ng/ml | 7.81 ± 4.55 (6.8;4.79/9.43) | 14.54 ± 17.84 (8.28;6.23/14.09) | <0.001 | 8.79 ± 8.16 (6.6;4.96/9.42) | 13.22 ± 18.22 (8.7;6.15/11.7) | <0.001 |
| Trygliceridemia, mg/dl | 130.65 ± 63.4 (105;83/163) | 136.23 ± 65.86 (122;86/161.5) | 0.648 | 130.92 ± 50.74 (126;94/152) | 135.25 ± 60 (126;94/152) | 0.552 |
| Glycaemia, mg/dl | 100.83 ± 19.68 (98;91/104) | 103.87 ± 21.1 (98;92/111) | 0.159 | 100.19 ± 20.85 (95;88/107) | 103.84 ± 23.15 (96;88/108) | 0.153 |
| HDL, mg/dl | 52.14 ± 11.73 (52;45/56) | 50.78 ± 12.34 (52;44/55.25) | 0.925 | 52.1 ± 11.14 (52;46/55) | 51.03 ± 12.99 (52;43/56.75) | 0.213 |
| Hypertension | 102/223 (47 %) | 74/126 (59 %) | 0.037 | 88/204 (43 %) | 91/145 (63 %) | 0.001 |
Kruskal Wallis test for continuous variables, chi square test for categorical variables. GS = Gleason score